Antimalarial drug combination policy: A caveat

Lancet

Volumn 355, Issue 9222, 2000, Pages 2245-2247

  Wongsrichanalai, Chansuda ^a   Thimasarn, Krongthong ^b   Sirichaisinthop, Jeeraphat ^c  

^a ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^b Dept Communic Dis Contr Min P   (Thailand)

^c Off of Vec Borne Dis Control No 1   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; MEFLOQUINE;

AFRICA; HEALTH CARE POLICY; HUMAN; MALARIA; MALARIA CONTROL; PRIORITY JOURNAL; REVIEW; THAILAND;

EID: 0034709756     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02416-8     Document Type: Note

References (19)

1. White N.J., Nosten F., Looareesuwan S.et al. Averting a malaria disaster. Lancet. 353:1999;1965-1967.
2. Wernsdorfer W.H., Chongsuphajaisiddhi T., Salazar N.P. A symposium on containment of mefloquine-resistant falciparum malaria in Southeast Asia with special reference to border malaria. Southeast Asian J Trop Med Public Health. 25:1994;11-18.
3. Fontanet A.L., Walker A.M. Predictors and treatment failure in multiple drug-resistant falciparum malaria. results from a 42-day follow-up of 224 patients in eastern Thailand Am J Trop Med Hyg. 49:1993;465-472.
4. Ketrangsee S., Vijaykadga S., Yamokgul P.et al. Comparative trial on the response of Plasmodium faciparum of halofantrine and mefloquine in Trat Province, eastern Thailand. Southeast Asian J Trop Med Public Health. 23:1992;55-58.
5. Thimasarn K., Sirichaisinthop J., Vijaykadga S.et al. In vivo study of the response of Plasmodium falciparum to standard mefloquine/sulfadoxine/pyrimethamine (MSP) treatment among gem miners returning from Cambodia. Southeast Asian J Trop Med Public Health. 26:1995;204-212.
6. Wongsrichanalai C., Webster H.K., WImonwattrawatee T.et al. Emergence of milti-drug resistant Plasmodium falciparum in Thailand: in vitro tracking. Am J Trop Med Hyg. 47:1992;112-116.
7. Nosten F., ter Kuile F., Chongsuphajaisiddhi T.et al. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet. 337:1991;1140-1143.
8. Annual Reports of the Malaria Division, Department of Communicable Disease Control, Ministry of Public Health, Thailand. Nonthaburi: Ministry of Public Health, 1992 & 1993.
9. Wongsrichanalai C., Wimonwattrawatee T., Sookto P.et al. In vitro sensitivity of Plasmodium falciparum to artesunate in Thailand. Bull World Health Organ. 77:1999;392-398.
10. White N.J. Drug resistance in malaria. Br Med Bull. 54:1998;703-715.
11. Wernsdorfer W.H. Epidemiology of drug resistance in malaria. Acta Tropica. 56:1994;143-156.
12. Kyle D.E., Teja-Isavadharm P., Li Q., Leo K. Pharmacokinetics and pharmacodynamics of qinghaosu derivatives: how do they impact on the choice of drug and dosage regimens? Med Trop (Mars). 58(suppl):1998;38-44.
13. Rathod P.K., McErlean T., Lee P.C. Variations in frequencies of drug resistance in Plasmodium falciparum. Proc Natl Acad Sci USA. 94:1997;9389-9393.
14. Basco L.K., Le Bras J. In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg. 49:1993;301-307.
15. Bustos M.D., Gay F., Diquet B. In vitro tests on Philippine isolates of Plasmodium falciparum against four standard anti-malarials and four qinghaosu derivatives. Bull World Health Organ. 72:1994;729-735.
16. Pradines B., Rogier C., Fusai T.et al. In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard anti-malarial drugs. Am J Trop Med Hyg. 58:1998;354-357.
17. von Seidlein L., Milligan P., Pinder M.et al. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomized, controlled trial. Lancet. 355:2000;352-357.
18. Price R.N., Nosten F., Luxemburger C.et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet. 347:1996;1654-1658.
19. Brundtland GH. Speech to the fifty-first World Health Assembly. Geneva: May 13, 1998.